Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (700)	9/20/1999 11:16:00 PM
From: Mike McFarland	Read Replies (3) \| Respond to of 4474

~30M shares at 7/8ths is trivial--if Ariad has the goods. The only other thing I remember seeing to compete with ARGENT is the Baylor Genepill-- RU486. What I would like to know...why was nobody around to support the share price through the summer. BancBoston could have been nice guys, apparently a buy means you buy, we hold. Strong buy must mean that they've finally started buying. And Ariad could have promoted themselves better--there are only something like 350 holders of record in the common, add another 100 who are willing to park the sort of money I have and you've lapped up a nice chunk of shares--nearly six million. However, I wonder if it does any good, for instance my brokerage probably turns around and lends my shares to shortsellers anyway, the whole thing seems to be crooked. An honest effort could have kept ARIA stock price at higher levels through the summer...that would have prevented further dilution, and there probably would not have been any talk of delisting either. But the fact is, that getting the stock down to 85 cents did something for somebody, and it was expected, and so it happened. Very likely now the market will perceive that Ariad has "bottomed" and maybe a slow climb is on tap now. Many questions remain. Why no mid year shareholder letter like last year, that was a real disappointment for me. Very hard to figure out...hey, maybe somebody should get one of those journalists on the case--how about that one from Forbes--Zina Moukheiber? You can be sure one of them will write something up when this is all over with...how long it takes, I've no idea. In fact, here is an old article by Zina forbes.com --boy, you would not wanted to have got into ARIA back in January '98--$4 a share. Of course risk is always -100%...upside varies;-)